2013
SUMMARY OF CONSOLIDATED FINANCIAL STATEMENTS For the Three Months of the Fiscal Year, Ending June 30 2014(From July 1, 2013 to September 30, 2013)
（135.6 KB）2013:12:04:10:11:38PSS and Roche enter into a new Development Agreement concerning emPCR Automation Instrument to be developed by PSS
2013:09:24:16:14:34SUMMARY OF CONSOLIDATED FINANCIAL STATEMENTS For Fiscal Year 2013 (From July 1, 2012 to June 30, 2013)
（145.5 KB）2013:09:03:15:09:28PSS and LG Life Sciences enter into a Supply and Distribution Agreement for PSS's "geneLEAD", a fully automated, sample-to-result system for NAT
2013:08:08:16:08:19PSS reaches Desalter Development Agreement with Abbott
2013:06:24:13:34:29PSS FY 2013 Third Quarter Financial Statements (Summary)
（137.5 KB）2013:05:29:11:10:31Termination of Agreement with Roche to develop a Fully Automated Emulsion PCR Instrument for Next-generation Sequencing Platforms
2013:05:09:15:09:34PSS and ELITech Group enter into a Joint Development, Distribution and Supply Agreement on PSS's "geneLEAD", a fully automated, sample-to-result, Real-Time PCR analyzer
2013:04:12:14:43:58PSS FY 2013 Second Quarter Financial Statements (Summary)
（148.6 KB）2013:02:26:16:31:43